Generation of Highly Purified Neural Stem Cells from Human Adipose-Derived Mesenchymal Stem Cells by Sox1 Activation
Publication: Stem Cells and Development
Volume 23, Issue Number 5
Abstract
Neural stem cells (NSCs) are ideal candidates in stem cell-based therapy for neurodegenerative diseases. However, it is unfeasible to get enough quantity of NSCs for clinical application. Generation of NSCs from human adipose-derived mesenchymal stem cells (hAD-MSCs) will provide a solution to this problem. Currently, the differentiation of hAD-MSCs into highly purified NSCs with biological functions is rarely reported. In our study, we established a three-step NSC-inducing protocol, in which hAD-MSCs were induced to generate NSCs with high purity after sequentially cultured in the pre-inducing medium (Step1), the N2B27 medium (Step2), and the N2B27 medium supplement with basic fibroblast growth factor and epidermal growth factor (Step3). These hAD-MSC-derived NSCs (adNSCs) can form neurospheres and highly express Sox1, Pax6, Nestin, and Vimentin; the proportion was 96.1%±1.3%, 96.8%±1.7%, 96.2%±1.3%, and 97.2%±2.5%, respectively, as detected by flow cytometry. These adNSCs can further differentiate into astrocytes, oligodendrocytes, and functional neurons, which were able to generate tetrodotoxin-sensitive sodium current. Additionally, we found that the neural differentiation of hAD-MSCs were significantly suppressed by Sox1 interference, and what's more, Step1 was a key step for the following induction, probably because it was associated with the initiation and nuclear translocation of Sox1, an important transcriptional factor for neural development. Finally, we observed that bone morphogenetic protein signal was inhibited, and Wnt/β-catenin signal was activated during inducing process, and both signals were related with Sox1 expression. In conclusion, we successfully established a three-step inducing protocol to derive NSCs from hAD-MSCs with high purity by Sox1 activation. These findings might enable to acquire enough autologous transplantable NSCs for the therapy of neurodegenerative diseases in clinic.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Feng Z and Gao F. (2012). Stem cell challenges in the treatment of neurodegenerative disease. CNS Neurosci Ther 18:142–148.
2.
Brown RC, Lockwood AH and Sonawane BR. (2005). Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect 113:1250–1256.
3.
Honig LS and Rosenberg RN. (2000). Apoptosis and neurologic disease. Am J Med 108:317–330.
4.
Mujtaba T, Piper DR, Kalyani A, Groves AK, Lucero MT and Rao MS. (1999). Lineage-restricted neural precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev Biol 214:113–127.
5.
Riess P, Zhang C, Saatman KE, Laurer HL, Longhi LG, Raghupathi R, Lenzlinger PM, Lifshitz J, Boockvar J, et al. (2002). Transplanted neural stem cells survive, differentiate, and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 51:1043–1052; discussion 1052–1054.
6.
Wong AM, Hodges H and Horsburgh K. (2005). Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Res 1063:140–150.
7.
Ben-Hur T, van Heeswijk RB, Einstein O, Aharonowiz M, Xue R, Frost EE, Mori S, Reubinoff BE and Bulte JW. (2007). Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn Reson Med 57:164–171.
8.
Einstein O, Fainstein N, Vaknin I, Mizrachi-Kol R, Reihartz E, Grigoriadis N, Lavon I, Baniyash M, Lassmann H and Ben-Hur T. (2007). Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 61:209–218.
9.
Einstein O, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Polyzoidou E, Lavon I, Milonas I, Karussis D, Abramsky O and Ben-Hur T. (2006). Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 198:275–284.
10.
Einstein O, Karussis D, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Abramsky O and Ben-Hur T. (2003). Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 24:1074–1082.
11.
Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D and Abramsky O. (2003). Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 41:73–80.
12.
Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del CU, Amadio S, et al. (2003). Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422:688–694.
13.
Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini A, Bergami A, et al. (2005). Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436:266–271.
14.
Hallbergson AF, Gnatenco C and Peterson DA. (2003). Neurogenesis and brain injury: managing a renewable resource for repair. J Clin Invest 112:1128–1133.
15.
Taghipour M and Razmkon A. (2012). Isolation and growth of neural stem cells derived from adult human hippocampus. J Inj Violence Res 4.
16.
Sun Y, Pollard S, Conti L, Toselli M, Biella G, Parkin G, Willatt L, Falk A, Cattaneo E and Smith A. (2008). Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture. Mol Cell Neurosci 38:245–258.
17.
Koch P, Opitz T, Steinbeck JA, Ladewig J and Brustle O. (2009). A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci U S A 106:3225–3230.
18.
Salewski RP, Buttigieg J, Mitchell RA, van der Kooy D, Nagy A and Fehlings MG. (2013). The generation of definitive neural stem cells from PiggyBac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway. Stem Cells Dev 22:383–396.
19.
Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF and Keiliss-Borok IV. (1974). Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331–340.
20.
Aust L, Devlin B, Foster SJ, Halvorsen YD, Hicok K, du Laney T, Sen A, Willingmyre GD and Gimble JM. (2004). Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy 6:7–14.
21.
Takemitsu H, Zhao D, Yamamoto I, Harada Y, Michishita M and Arai T. (2012). Comparison of bone marrow and adipose tissue-derived canine mesenchymal stem cells. BMC Vet Res 8:150
22.
Zhu X, Du J and Liu G. (2012). The comparison of multilineage differentiation of bone marrow and adipose-derived mesenchymal stem cells. Clin Lab 58:897–903.
23.
Nakagami H, Morishita R, Maeda K, Kikuchi Y, Ogihara T and Kaneda Y. (2006). Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy. J Atheroscler Thromb 13:77–81.
24.
Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, et al. (2011). Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13:675–685.
25.
Hsueh YY, Chiang YL, Wu CC and Lin SC. (2012). Spheroid formation and neural induction in human adipose-derived stem cells on a chitosan-coated surface. Cells Tissues Organs 196:117–128.
26.
Ahmadi N, Razavi S, Kazemi M and Oryan S. (2012). Stability of neural differentiation in human adipose derived stem cells by two induction protocols. Tissue Cell 44:87–94.
27.
Zhang SC. (2006). Neural subtype specification from embryonic stem cells. Brain Pathol 16:132–142.
28.
Li XJ, Du ZW, Zarnowska ED, Pankratz M, Hansen LO, Pearce RA and Zhang SC. (2005). Specification of motoneurons from human embryonic stem cells. Nat Biotechnol 23:215–221.
29.
Pankratz MT, Li XJ, Lavaute TM, Lyons EA, Chen X and Zhang SC. (2007). Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 25:1511–1520.
30.
Li K, Han Q, Yan X, Liao L and Zhao RC. (2010). Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev 19:1267–1275.
31.
Hermann A, Gastl R, Liebau S, Popa MO, Fiedler J, Boehm BO, Maisel M, Lerche H, Schwarz J, Brenner R and Storch A. (2004). Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 117:4411–4422.
32.
Jang S, Cho HH, Cho YB, Park JS and Jeong HS. (2010). Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin. BMC Cell Biol 11:25
33.
Chiba S, Kurokawa MS, Yoshikawa H, Ikeda R, Takeno M, Tadokoro M, Sekino H, Hashimoto T and Suzuki N. (2005). Noggin and basic FGF were implicated in forebrain fate and caudal fate, respectively, of the neural tube-like structures emerging in mouse ES cell culture. Exp Brain Res 163:86–99.
34.
Liang P, Zhao S, Kawamoto K, Jin L and Liu E. (2003). Neuronal and glial differentiation following culture of the human embryonic cortical stem cells. Hum Cell 16:151–156.
35.
Joo KM, Kang BG, Yeon JY, Cho YJ, An JY, Song HS, Won JH, Kim SJ, Hong SC and Nam DH. (2013). Experimental and clinical factors influencing long-term stable in vitro expansion of multipotent neural cells from human adult temporal lobes. Exp Neurol 240:168–177.
36.
Zhao J, Sun W, Cho HM, Ouyang H, Li W, Lin Y, Do J, Zhang L, Ding S, et al. (2013). Integration and long distance axonal regeneration in the central nervous system from transplanted primitive neural stem cells. J Biol Chem 288:164–168.
37.
Elkabetz Y, Panagiotakos G, Al SG, Socci ND, Tabar V and Studer L. (2008). Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 22:152–165.
38.
Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick MH. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279–4295.
39.
Ashjian PH, Elbarbary AS, Edmonds B, DeUgarte D, Zhu M, Zuk PA, Lorenz HP, Benhaim P and Hedrick MH. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plast Reconstr Surg 111:1922–1931.
40.
Richter H, Klee R, Heinemann U and Eder C. (1997). Developmental changes of inward rectifier currents in neurons of the rat entorhinal cortex. Neurosci Lett 228:139–141.
41.
Furlan F, Guasti L, Avossa D, Becchetti A, Cilia E, Ballerini L and Arcangeli A. (2005). Interneurons transiently express the ERG K+ channels during development of mouse spinal networks in vitro. Neuroscience 135:1179–1192.
42.
Venere M, Han YG, Bell R, Song JS, Alvarez-Buylla A and Blelloch R. (2012). Sox1 marks an activated neural stem/progenitor cell in the hippocampus. Development 139:3938–3949.
43.
Guth SI and Wegner M. (2008). Having it both ways: Sox protein function between conservation and innovation. Cell Mol Life Sci 65:3000–3018.
44.
Nitta KR, Takahashi S, Haramoto Y, Fukuda M, Onuma Y and Asashima M. (2006). Expression of Sox1 during Xenopus early embryogenesis. Biochem Biophys Res Commun 351:287–293.
45.
Pevny LH, Sockanathan S, Placzek M and Lovell-Badge R. (1998). A role for SOX1 in neural determination. Development 125:1967–1978.
46.
Malas S, Postlethwaite M, Ekonomou A, Whalley B, Nishiguchi S, Wood H, Meldrum B, Constanti A and Episkopou V. (2003). Sox1-deficient mice suffer from epilepsy associated with abnormal ventral forebrain development and olfactory cortex hyperexcitability. Neuroscience 119:421–432.
47.
Tanaka S, Kamachi Y, Tanouchi A, Hamada H, Jing N and Kondoh H. (2004). Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Mol Cell Biol 24:8834–8846.
48.
Ou Y, Yuan XD, Cai YN and Lu YH. (2011). Ultrastructure and electrophysiology of astrocytes differentiated from adult adipose-derived stromal cells. Chin Med J (Engl) 124:2656–2660.
49.
Liao D, Gong P, Li X, Tan Z and Yuan Q. (2010). Co-culture with Schwann cells is an effective way for adipose-derived stem cells neural transdifferentiation. Arch Med Sci 6:145–151.
50.
Wang B, Han J, Gao Y, Xiao Z, Chen B, Wang X, Zhao W and Dai J. (2007). The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs. Neurosci Lett 421:191–196.
51.
Chen J, Tang YX, Liu YM, Chen J, Hu XQ, Liu N, Wang SX, Zhang Y, Zeng WG, et al. (2012). Transplantation of adipose-derived stem cells is associated with neural differentiation and functional improvement in a rat model of intracerebral hemorrhage. CNS Neurosci Ther 18:847–854.
52.
Zavan B, Michelotto L, Lancerotto L, Della PA, D'Avella D, Abatangelo G, Vindigni V and Cortivo R. (2010). Neural potential of a stem cell population in the adipose and cutaneous tissues. Neurol Res 32:47–54.
53.
Qian DX, Zhang HT, Ma X, Jiang XD and Xu RX. (2010). Comparison of the efficiencies of three neural induction protocols in human adipose stromal cells. Neurochem Res 35:572–579.
54.
Kirkeby A, Grealish S, Wolf DA, Nelander J, Wood J, Lundblad M, Lindvall O and Parmar M. (2012). Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep 1:703–714.
55.
Chenn A and Walsh CA. (2002). Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365–369.
56.
Oelgeschlager M, Kuroda H, Reversade B and De Robertis EM. (2003). Chordin is required for the Spemann organizer transplantation phenomenon in Xenopus embryos. Dev Cell 4:219–230.
57.
Gerrard L, Rodgers L and Cui W. (2005). Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 23:1234–1241.
58.
Pevny L and Placzek M. (2005). SOX genes and neural progenitor identity. Curr Opin Neurobiol 15:7–13.
Information & Authors
Information
Published In
Stem Cells and Development
Volume 23 • Issue Number 5 • March 1, 2014
Pages: 515 - 529
PubMed: 24138016
Copyright
Copyright 2014, Mary Ann Liebert, Inc.
History
Published in print: March 1, 2014
Published ahead of print: 20 January 2014
Published online: 18 October 2013
Accepted: 18 October 2013
Received: 9 June 2013
Topics
Authors
Author Disclosure Statement
The authors have no conflicts of interest.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.